Mirabegron — ingredient monograph

Overview

Source: NDC Directory

Ingredient name

MIRABEGRON

Base moiety

MIRABEGRON

RxNorm CUI

1300791

UNII

MVR3JL3B2V

Medication products

9

Brand names

4

Dosage forms

5

FAERS reports

38,466 · not a risk measure

Products containing this ingredient

Source: NDC Directory 9 products

Brivaracetam Powder
13 NDC
Mirabegron Powder
24 NDC
Mirabegron For Suspension, Extended Release
Rx ANDA TE AB 1 NDC
Mirabegron (Alpha-Form) Powder
1 NDC
Mirabgeorn mirabegron · Tablet, Film Coated, Extended Release
Rx ANDA TE AB 1 NDC
Myrbetriq mirabegron · Granule, for Suspension, Extended Release
Rx NDA TE AB 1 NDC
mirabegron Tablet, Film Coated, Extended Release
Rx ANDA TE AB 10 NDC
Mirabegron Tablet, Extended Release
Rx ANDA TE AB 1 recall 6 NDC
Myrbetriq mirabegron · Tablet, Film Coated, Extended Release
Rx NDA TE AB 2 NDC

Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.

By dosage form

How this ingredient is presented across the catalogue.
Dosage form	Products	Examples
Powder	3	Brivaracetam, Mirabegron, Mirabegron (Alpha-Form)
TABLET, Film COATED, Extended Release	3	Mirabgeorn, mirabegron, Myrbetriq
For SUSPENSION, Extended Release	1	Mirabegron
GRANULE, For SUSPENSION, Extended Release	1	Myrbetriq
TABLET, Extended Release	1	Mirabegron

Sources for this page

Dataset	Agency	Used for
NDC Directory	FDA	Ingredient name, strengths, products, labelers, packages
DailyMed RxNorm mappings	NLM	RxNorm concept identifier (RxCUI)
FAERS	FDA	Adverse event report totals